Heart bypass patients may benefit from cheap gout drug to keep grafts open
NCT ID NCT07569328
First seen May 07, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tests whether taking a low dose of colchicine (0.5 mg daily) after coronary artery bypass grafting (CABG) can reduce the chance of graft failure. About 622 adults who recently had bypass surgery will receive either colchicine or a placebo for 24 months. The main goal is to see if the drug helps keep the new blood vessels open, as measured by a special CT scan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CABG are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital
Beijing, Beijing Municipality, 100029, China
Conditions
Explore the condition pages connected to this study.